Cargando…
Comparative study of two doses of intrathecal dexmedetomidine as adjuvant with low dose hyperbaric bupivacaine in ambulatory perianal surgeries: A prospective randomised controlled study
BACKGROUND AND AIMS: Dexmedetomidine (DMT), as intrathecal adjuvant has been shown to successfully prolong duration of analgesia but delay the motor recovery. Hence, this study was designed to find out the dose of DMT which can provide satisfactory analgesia without prolonging motor block. METHODS:...
Autores principales: | Sudheesh, K, Rao, RS Raghavendra, Kavya, M, Aarthi, J, Rani, D Devika, Nethra, SS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645353/ https://www.ncbi.nlm.nih.gov/pubmed/26644612 http://dx.doi.org/10.4103/0019-5049.167485 |
Ejemplares similares
-
Effect of supplementation of low dose intravenous dexmedetomidine on characteristics of spinal anaesthesia with hyperbaric bupivacaine
por: Harsoor, SS, et al.
Publicado: (2013) -
Intrathecal dexmedetomidine as adjuvant for spinal anaesthesia for perianal ambulatory surgeries: A randomised double-blind controlled study
por: Nethra, SS, et al.
Publicado: (2015) -
Dexmedetomidine as Adjuvant to Lower Doses of Intrathecal Bupivacaine for Lower Limb Orthopedic Surgeries
por: Mohamed, Taznim, et al.
Publicado: (2017) -
Effect of intrathecal dexmedetomidine versus intravenous dexmedetomidine on subarachnoid anesthesia with hyperbaric bupivacaine
por: Sharma, Anshu, et al.
Publicado: (2020) -
Single dose intravenous dexmedetomidine prolongs spinal anesthesia with hyperbaric bupivacaine
por: Kubre, Jyotsna, et al.
Publicado: (2016)